C4 Imaging
9 articles about C4 Imaging
-
C4 Imaging Announces FDA 510(k) Clearance of its Positive-Signal High Dose Rate (HDR) Brachytherapy MRI Treatment Planning Marker
5/8/2018
This novel, Positive-Signal MRI Marker will be used prior to high dose rate (HDR) brachytherapy to accurately locate the position of the applicators that guide the placement of radioactive sources for the treatment of multiple cancers.
-
C4 Imaging Lands Additional FDA 510(k) Clearance for Its Positive-Signal MRI Marker
9/6/2017
-
MRI Assisted Radiosurgery (MARS) Utilizing C4 Imaging's Sirius Positive-Signal MRI Marker Is A Cost-Effective Option For The Treatment Of Prostate Cancer
8/8/2017
-
Clinical Study Discusses The Value Of C4 Imaging's Sirius Positive-Signal MRI Marker In MRI-Guided Prostate Cancer Treatment
7/6/2016
-
C4 Imaging Receives Top Honors At The 5th Annual Texas Life Science Forum
6/6/2016
-
C4 Imaging Utilizes Evonik's VESTAKEEP PEEK For Prostate Cancer Device
9/23/2015
-
C4 Imaging Awarded $1.3 Million NIH SBIR Phase II Grant
8/21/2015
-
C4 Imaging Announces First Sirius™ Positive Signal MRI Marker Implant
4/7/2014
-
C4 Imaging Announces FDA 510(k) Clearance Of Its Positive-Signal MRI Marker - Sirius™
12/9/2013